Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 6306-52-1 | MDL No. : | MFCD00012497 |
Formula : | C6H14ClNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KUGLDBMQKZTXPW-JEDNCBNOSA-N |
M.W : | 167.63 | Pubchem ID : | 111190 |
Synonyms : |
H-Val-OMe.HCl
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.83 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 41.91 |
TPSA : | 52.32 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.35 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 1.37 |
Log Po/w (WLOGP) : | 0.94 |
Log Po/w (MLOGP) : | 0.75 |
Log Po/w (SILICOS-IT) : | 0.0 |
Consensus Log Po/w : | 0.61 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.54 |
Solubility : | 4.79 mg/ml ; 0.0285 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.07 |
Solubility : | 1.42 mg/ml ; 0.00848 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -0.43 |
Solubility : | 61.9 mg/ml ; 0.369 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.57 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
72% | With triethylamine In dichloromethane at 0 - 25℃; for 20h; | |
With pyridine; sodium acetate | ||
With triethylamine In dichloromethane at 0℃; for 18h; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With Sodium hydrogenocarbonate In tetrahydrofuran; methanol at 20℃; for 20h; | |
96% | With Sodium hydrogenocarbonate In tetrahydrofuran; methanol at 0 - 20℃; Inert atmosphere; | |
94% | With Sodium hydrogenocarbonate In tetrahydrofuran; methanol at 0 - 20℃; for 20h; Inert atmosphere; |
93.8% | With Sodium hydrogenocarbonate In tetrahydrofuran; methanol at 0 - 20℃; for 20h; Inert atmosphere; | |
92% | With Sodium hydrogenocarbonate In tetrahydrofuran; methanol at 0 - 20℃; Inert atmosphere; | |
92% | With Sodium hydrogenocarbonate In tetrahydrofuran; methanol at 0 - 20℃; Inert atmosphere; | |
75% | With Sodium hydrogenocarbonate In tetrahydrofuran; methanol Inert atmosphere; | |
71.44% | With triethylamine In dichloromethane at 0 - 20℃; for 5.5h; | 92.1 1. Preparation of compound 2. To a solution of compound 1 (70.00 g, 417.59 mmol HC1) in DCM (300 mL) was added Et3N (126.77 g, 1.25 mol), then the mixture was cooled to 0 °C and slowly added (Boc)20 (136.71 g, 626.39 mmol) (a solution in DCM (200 mL)) over 0.5 hr. The mixture was stirred at 20 °C for 5 hr. TLC showed the starting material was consumed and one major spot was detected. The resulting mixture was filtered, solid removed, and then the organic solvent was concentrated under reduced pressure to give a residue. The residue was purified by column chromatography (Si02, Petroleum ether: Ethyl acetate = 100:1 to 5:1). Compound 2 was obtained as a colorless oil (69.00 g, 71.44%). ‘HNMR (400 MHz, CHLOROFORM-d) = 5.01 (br d, J=7.9 Hz, 1H), 4.20 (br dd, J=4.7, 8.9 Hz, 1H), 3.75 - 3.63 (m, 3H), 2.20 - 2.00 (m, 1H), 1.49 - 1.33 (m, 9H), 0.93 (d, J=6.8 Hz, 3H), 0.87 (d, J=6.8 Hz, 3H). TLC (Petroleum ether / Ethyl acetate = 5: 1) Rf= 0.60. |
Yield given; | ||
With Sodium hydrogenocarbonate In tetrahydrofuran; methanol for 20h; Ambient temperature; | ||
With triethylamine In chloroform at 20℃; | ||
With Sodium hydrogenocarbonate In ethanol at 20℃; for 48h; | 4.5.11. (S)-6,6-Dimethyl-2-phenyl-5-isopropyl-5,6-dihydrooxazolo[2,3-c][1,2,4]triazol-2-ium tetrafluoroborate 51 To a suspension of (S)-valine methyl ester hydrochloride (20.0 g, 119 mmol) in EtOH (60 mL) was added NaHCO3 (26.1 g, 310 mmol) and Boc2O (29.6 g, 136 mmol). The mixture was stirred for 48 h at ambient temperature then the colourless suspension was filtered through Celite and the filtrate concentrated in vacuo to afford the carbamate product as a pale yellow oil (27.5 g, quantitative) which was used without further purification. inlMMLBox (c 0.5, AcOH), lit.47 -6.3 (c 1, AcOH); δH (400 MHz, CDCl3) 5.05 (1H, d, J 8.7, CHNH), 4.17 (1H, ABX, JXA 8.7, JXB 4.8, CHNH), 3.68 (3H, s, OCH3), 2.16-1.98 (1H, m, CHMe2), 1.51-1.34 (9H, m OC(CH3)3), 0.90 (3H, d, J 6.9, CH(CH3)A) and 0.85 (3H, d, J 6.9, CH(CH3)B). Data are in accordance with the literature.47 | |
With triethylamine In methanol at 25℃; for 2h; | B.B3 L- Valine methylester hydrochloride (50 g, 0.30 mol) and 200 g of methanol were added to a vessel. Triethylamine (37.5 ml, 0.27 mol) was charged and the reaction temperature was kept at <25 °C. Then di-tert-butyl dicarbonate (68.3 g, 0.31 mol) was charged. After that, triethylamine (63.7 ml, 0.46 mol) was charged dropwise, while controlling the reaction temperature at <25 °C. The mixture was stirred at 25 °C for 2 hrs until TLC showed no remaining starting material. Thereafter methanol was removed under reduced pressure. Methyl isobutyl ether (200 ml) was charged, followed by addition of water (150 ml) and then the mixture was stirred for 30 min. The layers were separated, the aqueous phase was extracted with methyl tert-butylether (100 ml). The combined organic phases were washed with NaCl solution (150 ml), dried with Na2S04 (10 g), then filtered, and the filtrate was concentrated under reduced pressure until dryness. Boc-L- valine methylester (74.5 g) was obtained as crude product which could directly be used for the subsequent reaction. . | |
29 g | With triethylamine In dichloromethane at 20℃; for 17h; Inert atmosphere; | |
With Sodium hydrogenocarbonate In tetrahydrofuran; methanol at 0 - 20℃; for 20h; | ||
With triethylamine In methanol; dichloromethane at 0 - 20℃; for 19h; | ||
With triethylamine |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
38% | With triethanolamine; diphenyl-phosphinic acid; In tetrahydrofuran; ethyl acetate; | The N-benzoyl-L-phenylalanyl-L-valine used as the starting material was prepared as follows: In 100 ml of tetrahydrofuran (THF) were dissolved 13.5 g of <strong>[2566-22-5]N-benzoyl-L-phenylalanine</strong> and 8.4 g of L-valine methyl ester hydrochloride, after which 13.8 g of DPPA and 14.0 ml of TEA were added to the solution with ice-cooling. The resulting mixture was stirred at room temperature for 24 hrs. The reaction mixture was evaporated under reduced pressure to dryness, and the residue was dissolved in ethyl acetate. The solution was washed with 10% citric acid solution, saturated sodium bicarbonate solution and saturated sodium chloride solution in this order, dried over anhydrous magnesium sulfate, and then evaporated under reduced pressure to dryness. The residue was recrystallized from ethyl acetate-n-hexane to obtain 7.3 g (yield 38%) of white powder of N-benzoyl-L-phenylalanyl-L-valine methyl ester, m.p. 160-163 C. IR numaxKBr cm-1: 3300, 1730, 1630. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
75% | With 4-methyl-morpholine In chloroform | |
75% | With 4-methyl-morpholine In chloroform |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In diethyl ether; | [(S) -2-amino-3-methyl-1,1-diphenylbutan- 1-ol] Synthesis of (5): The above (5) Org. Chem. 2009, 74, 2541-2546. Stated in Was synthesized |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In tetrahydrofuran; at 20℃; for 72h;Molecular sieve;Product distribution / selectivity; | A mixture of L-Valine methyl ester hydrochloride (548 mg), 4-(5,5-dimethyl- [1 ,3,2]dioxaborinan-2-yl)-benzaldehyde (476 mg) and molecular sieves in anhydrous THF (17 ml_) was stirred at room temperature for three days. Then, the mixture was cooled to O0C and a solution of NaBH3CN (155 mg) in dry MeOH (3 ml_) was added dropwise. The mixture was stirred at room temperature for 4 hours and the solids were removed by filtration. The filtrate was evaporated under vacuum to yield the desired product (632 mg) that was used in the next reaction without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In toluene; | EXAMPLE 3 (N-(2-tetrahydrofuroyl)-(S)-valine methyl ester) 30.4 g (0.226 mol) of <strong>[52449-98-6]tetrahydrofuran-2-carbonyl chloride</strong> were heated to 50 C. with 41 g (0.246 mol) of (S)-valine methyl ester hydrochloride in 50 ml of toluene with stirring until evolution of HCl was complete (about 20 hours). The mixture was extracted by shaking with a little water and distilled. Yield of N-(2-tetrahydrofuroyl)-(S)-valine methyl ester (formula V with X=S, n=1, R=CH(CH3)2 and R'=CH3): 48.4 g (94%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20℃;Inert atmosphere; | General procedure: To a solution of trifluorocrotonic acid (1.0 equiv) in DMF, was added the amino acid methyl ester hydrochloride (1.2 equiv), DIPEA (4.0 equiv), HBTU (1.2 equiv) and HOBt (1.2 equiv) in this order. The mixture was stirred overnight at room temperature under argon atmosphere. The solvent was evaporated under vacuum and the residue dissolved in ethyl acetate. The organic layer was washed with 10% citric acid aqueous solution (two times), water, 10% K2CO3aqueous solution (two times) and brine, dried over Na2SO4, filtrated and evaporated. The crude product was purified by column chromatography (EtOAc/cyclohexane: 3/7) to afford the corresponding alkene. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
54% | With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In N,N-dimethyl-formamide; at 0 - 20℃; for 50h; | General procedure: Mycophenolic acid 1 (0.156 mmol), methyl ester amino acid hydrochloride 9 (0.178 mmol) and DMAP (0.178 mmol) was dissolved in dry DMF (3 mL). A reaction mixture was cooled to 0 C in an ice bath and with stirring was added EDCI (0.17053 mmol). The solution was stirred at 0 C for 2 h and after that time left at room temperature for 48 h. Progress of the reaction controlled by TLC plates. After completion of the reaction solution was poured into water (15 mL), extracted with ethyl acetate. The organic layer was separated, dried (MgSO4), filtered and concentrated. The crude products were purified by chromatography (SiO2). Structures of synthesized derivatives 10 were established by spectroscopic methods (1H NMR, 13C NMR, MS, HPLC-MS, optical rotation and melting point). Ester hydrolysis: the methyl ester 10 was dissolved in MeOH (30 mL/g), and a solution of LiOH*H2O (3 mol equiv - 2-fold more for 10d and 10e) in an equal volume of water was added. When hydrolysis was complete (48 h), the solution was added to water and washed with ether. The aqueous phase was acidified with 2 N HCl and extracted with EtOAC. The extract was dried with MgSO4 and evaporated, and the residue was recrystallized [17]. |
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine; In chloroform; at 20℃;Inert atmosphere; | Mycophenolic-L-Valine methyl ester (23).To the solution of MPA (1g, 3.13 mmol) in CHCl3 (35 mL) were addedEDC (660 mg, 3.44 mmol) and valine methyl ester hydrochloride (524.7 mg, 3.13mmol) followed by TEA (480 uL, 3.44 mmoL). Mixture was stirred overnight at rt.Evaluated by TLC: silica gel, CHCl3:MeOH, 9:1. Reaction mixture waswashed with water (3 x 15 mL), citric acid (0.5 M), and brine, organicphase was dried over MgSO4, filtered and evaporated leaving whitecrystalline product. 1H NMR (CDCl3)deltappm 5.93 (d, J = 8.22 Hz, 1H), 5.27 (t, J = 6.64 Hz, 1H), 5.20(s, 2H), 4.54 (dd, J = 8.76, 4.88 Hz, 1H), 3.76 (s, 3H), 3.72 (s, 3H),3.39 (d, J = 6.97 Hz, 2H), 2.37-2.29 (m, 4H), 2.15 (s, 3H), 2.13-2.06(m, 1H), 1.82 (s, 3H), 0.89 (d, J = 6.85 Hz, 3H), 0.86 (d, J = 6.90Hz, 3H). HRMS calcdfor C23H30NO7 432.2028 (M-H)-,found 432.2035. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | General procedure: To a stirred suspension of theophyline-7-acetic acid (200 mg, 1 eq) and L-aminoacid methyl ester.HCl (1.05 eq) in CH2Cl2 (20 ml) was added N-ethyldiisopropylamine (1.1 eq). After 10 min the reaction became a clear solution and EDC (1.1 eq), and HOBt (1.1 eq) were added. The mixture was stirred overnight at r.t., then washed with water (2 x 20 ml) and sat. aq. NaHCO3 (20 ml). For hygroscopic compounds (2a-b, 2e, 2h), was done a back-extraction of the combined aqueous layers with CH2Cl2:MeOH = 10:1. The combined organic layers were dried over Na2SO4 and concentrated under reduced pressure. The product was purified by filtration through a pad of silica gel (EtOAc/MeOH = 4:1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
37%; 34% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine; In dichloromethane; at 0 - 20℃; | General procedure: To a solution of <strong>[73112-09-1]2-cyanonicotinic acid</strong> (4; 740 mg, 5 mmol) in CH2Cl2(30 mL) were added Et3N (1.39 mL, 10 mmol), the corresponding methyl ester of an amino acid hydrochloride (5 mmol) and HOBt (0.675 g, 5 mmol). The mixture was stirred at 0 and EDCI (0.967 g,5.05 mmol) was added. Then, the mixture was stirred at r.t. overnight.The mixture was diluted with CH2Cl2 (50 mL); then, the solution was washed with 0.1 M HCl (3 × 15 mL) and brine (20 mL), dried over MgSO4 and concentrated in vacuo. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
General procedure: To a cold and stirred dry dichloromethane solution (25 mL, -20 C) of nalidixic acid (1 mmol),ethyl chloroformate (1 mmol) and triethylamine (1 mmol) were successively added. After 10 min,a cold methylene chloride solution (10 mL, -20 C) of an amino acid methyl ester, namely L-Valinemethyl ester, L-Leucine methyl ester, or L-Phenylalanine methyl ester (1 mmol) was added, with continuous stirring for 3 h and at RT overnight. The solution was then washed with water, 1 N HCl,1 N NaHCO3, and finally with water (250 mL). The solution was dried on anhydrous CaCl2 andevaporated. The oily residue was solidified by trituration with dry ether, filtered off, dried undervacuum, and recrystallized to afford the esters 2a-c, respectively, as previously described [37]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
38% | To dichloromethane (3mL) solution of ethylphosphonic dichloride (135mg, 0.829mmol), Methyl L-Valine Hydrochloride (139mg, 0.829mmol) was added, -78C at triethylamine (168mg, 1.66mmol) was added dropwise dichloromethane (2mL) solution. After 1 h stirring the reaction mixture at room temperature, Compound III-2 (200mg, 0.414mmol) and triethylamine (126 mg, 1.25 mmol) and the mixture was stirred for 6 hours at the same temperature. The reaction mixture was concentrated and purified by silica gel column chromatography (ethyl acetate - methanol) to give the compound II-55 (112mg, 38% yield) | |
38% | Ethyl phosphorodichloridate (135 mg, 0.829 mmol)In dichloromethane (3 mL) was added L-valine methyl hydrochloride(139 mg, 0.829 mmol) was added, and a solution of triethylamine (168 mg, 1.66 mmol) in dichloromethane (2 mL) was added dropwise at -78 C. After stirring the reaction solution at room temperature for 1 hour, compound III-2 (200 mg, 0.414 mmol) and triethylamine (126 mg, 1.25 mmol) were added and stirred at the same temperature for 6 hours. The reaction solution was concentrated and purified by silica gel column chromatography (ethyl acetate-methanol) to obtain compound II-55 (112 mg, yield 38%) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
25% | With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine; In N,N-dimethyl-formamide; at 20℃; for 18h;Cooling with ice; | To L-valine methyl ester hydrochloride (500 mg, 2.98 mmol) were added N, N-dimethylformamide (29.8 ml) and behenic acid (1.52 g, 4.47 mmol) at room temperature, and the mixture was cooled in an ice bath. Then, l-ethyl-3- (3- dimethylaminopropyl) carbodiimide hydrochloride (857 mg, 4.47 mmol), 1-hydroxybenzotriazole (604 mg, 4.47 mmol), and (1030) triethylamine (1.25 ml, 8.94 mmol) were added, and the mixture was removed from the ice bath and stirred at room temperature for 18 hr. Thereafter, ethyl acetate (70 ml) was added and the mixture was filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (hexane/ethyl acetate) . The obtained solid was slurry washed with diethyl ether (30 ml) to give N- docosanoyl-L-valine methyl ester (331 mg, 0.73 mmol, yield 25%) as a white solid. (1031) 1H-NMR (400 MHz, CDC13)5: 0.86-0.95(m, 9H) , 1.25-1.33 (m, 36H) , 1.64(m, 2H) , 2.15(dsep, 1H, J=4.8 Hz, 6.8 Hz), 2.23(t, 2H, J=7.6 Hz), 3.74(s, 3H) , 4.59(dd, 1H, J=4.8 Hz, 8.8 Hz), 5.88(d, 1H, J=8.4 Hz) . (1032) ESIMS(m/z): 454.4 ( [M+H] +) , 907.8 ( [2 M+H] +) . |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | To a solution of Fmoc-aminoacetaldehyde 3 (140 mg, 0.5 mmol, 1.0 equiv) in dry MeOH (8.0 mL) was added Valine methyl ester hydrochloride (167 mg,I. 0 mmol, 2.0 equiv) and the solution was stirred utile complete dissolution of the solids. To this mixture was then added a solution of adenine acetic acid 2b (293 mg, 1.0 mmol, 2.0 equiv) in dry THF (4.0 mL) and subsequently benzyl isocyanide (60 u.L, 0.5 mmol, 1.0 equiv) was added in one portion, and the mixture was stirred at room temperature until completion of the reaction, as judged by LC-MS analysis. The solvents were then evaporated in vacuo, and the crude mixture was purified by flash chromatography (silica gel, gradient 92/8 to 90/10 CH2CI2/MeOH) yielding the desired open chain Ugi product |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | With triethylamine In dichloromethane at 38 - 40℃; | Preparation of Methyl (tert-butoxycarbonyl)-L-phenylalaninate (Table 2, entry 1). General procedure: L-Phenylalanine methyl ester hydrochloride (5.0 g, 23.2 mmol), triethyl amine (2.47 g, 24.4 mmol) and 2 (7.24 g, 24.4 mmol) were added to dichloromethane (50 mL) and stirred at reflux temp (38-40°C) for 5h. After completion of the reaction, filtered to remove salts and the filtrate was washed with 5% KHSO4 (20 mL), water (25 mL), brine (25 mL), and dried over sodium sulfate. The solvent was evaporated under reduced pressure to obtain a pale yellow oil. The oil was purified by column chromatography (silica gel, ethyl acetate/ hexane, 8:2) to afford 5.96 g (92%) Methyl (tert-butoxycarbonyl)-L-phenylalaninate as a colorless oil. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
45% | With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 25℃; for 20h; | Compound 2 (0.450 g, 1.43 mmol) was dissolved in 4 mL DMF. To this was added HBTU (0.619 g, 1.63 mmol) and DIEA (0.48 mL, 2.73 mmol) to generate the activated ester. After 10 min, l-Valine methyl ester hydrochloride (0.23 g, 1.37 mmol) was added and the reaction mixture was stirred under nitrogen overnight. The reaction was diluted with EtOAc (20 mL) and an equal amount of sodium bicarbonate, washed with brine (6 * 20 mL), dried (MgSO4) and concentrated in vacuo. The crude product was subjected to column chromatography (Hexane/EtOAc, 2:3 v/v) yielding 8 as a white solid (0.26 g, 45%). 1H NMR (400 MHz, CDCl3) δ 7.21 (d, J = 8.4 Hz, 1H, 1 * P1-Val-NH), 5.25 (d, J = 9.3 Hz, 1H, 1 * P3-Val-carbamate-NH), 4.64-4.54 (m, 1H, 1 * P1-Val-αH), 4.42 (dd, J = 8.4, 5.1 Hz, 1H, 1 * P2-Pro-αH), 4.29 (dd, J = 9.4, 6.2 Hz, 1H, 1 * P3-Val-αH), 3.72 (s, 3H, OCH3), 3.78-3.66 (m, 1H, 1 * P2-Pro-δH), 3.64-3.54 (m, 1H, 1 * P2-Pro-δH), 2.40-2.28 (m, 1H, 1 * P1-Val-βH), 2.19-2.03 (m, 2H, 2 * P2-Pro-βH), 2.01-1.91 (m, 2H, 1 * P3-Val-βH and 1 * P2-Pro-γH), 1.88-1.75 (m, 1H, 1 * P2-Pro-γH), 1.42 (s, 9H, tButyl), 0.98 (d, J = 6.8 Hz, 3H, 3 * P1-Val-γH), 0.94-0.87 (m, 9H, 3 * P1-Val-γH and 6 * P3-Val-γH). 13C NMR (101 MHz, CDCl3) δ 172.58, 172.12, 170.92, 155.80, 79.56, 59.92, 57.54, 56.77, 52.04, 47.68, 31.43, 31.09, 28.32, 27.20, 25.15, 19.55, 18.94, 17.86, 17.40. ESI-MS (m/z): calcd for C21H37N3NaO6 (M + Na) m/z 450.2580 found 450.2540. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In dichloromethane; at 20℃; for 24h; | In a two necked round flask equipped with a condenser were placed at room temperature 2.34 g of BOP (5.26 10 -"3 mol), 2.34 mL of diisopropylethylamine (1.8 10- 2 mol), 1.2 g of 4-(Hexyloxy)benzoic acid(5.40 10" mol) and 0.88 g of L- Valine methyl ester hydrochloride (5.25 10" mol) in 15 mL of CH2C12. The mixture was placed under stirring at room temperature for 24 hours. Water was added to allow phase separation. The bottom phase layer was washed with NaHC03 (10%) solution, dried over Na2S04, filtered and concentrated in vacuo. After removal of the solvents, the crude residue was purified by chromatography on a silica gel column using CH2C12/Ethylacetate (1/1) eluent affording the expected product compound 472 in 85% yield. White solid; 1H NMR (CDCl3): delta= 8.06 (m, 2H), 7.15 (m, 2H), 4.15-4.22 (m, 4H), 3.71- 3.75 (m, 3H), 1.81-2.05 (m, 3H), 1.21-1.37 (m, 6H), 0.69-0.92 (m, 9H). 13C (CDCl3): delta = 172.90, 166.54, 160.52, 133.08, 130.21, 130.01, 114.55, 68.22, 57.56, 52.34, 33.49, 31.32, 29.34, 25.67, 22.61, 18.48, 14.03 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In N,N-dimethyl-formamide; at 0 - 20℃; | General procedure: To a stirred solutionof <strong>[50264-69-2]Lonidamine</strong> (200mg, 0.62mmol) and HOBt anhydrous(84 mg, 0.61 mmol) in DMF (5 mL), EDC·HCl(119 mg, 0.61 mmol) and NMM (0.61 mmol, 0.07 mL)were added at 0 C, followed by an ice-cold suspensionof amino acid derivative as hydrochloride or TFA salt andNMM (0.61mmol, 0.07mL) in DMF (5mL). After 10minat 0C, the reaction was stirred at r.t overnight. Later, thereaction mixture was evaporated to dryness and the residuewas taken up in EtOAc. The organic phase was washed with5% citric acid, NaHCO3s.s. and NaCl s.s., dried on Na2SO4anhydrous and evaporated to obtain the desired crude whiteproduct. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; Inert atmosphere; | 4.1.4. General procedure for the synthesis of amino acid derivatives28e40 and 56 General procedure: To a stirred solution of the corresponding propionic acid derivative(23e27 or 55) (1 eq, 1.0 mmol) and L-aminoacid methylester hydrochloride (Alanine, Valine or Phenylalanine) (1 eq, 1.0 mmol) in dry dichloromethane, N-Ethyl-N0-(3-dimethylaminopropyl)carbodiimide hydrochloride (2 eq,2.0 mmol) and triethylamine (2 eq, 2 mmol) were added. Themixture was stirred under argon atmosphere during 5e16 h atroom temperature. After completion, the resulting mixture waswashed twice with 1 N HCl solution, once with water, once withbrine, dried over Na2SO4, and evaporated in vacuo. Crude was purifiedby column chromatography eluting with dichloromethanemethanol(100e98:2). |
Tags: 6306-52-1 synthesis path| 6306-52-1 SDS| 6306-52-1 COA| 6306-52-1 purity| 6306-52-1 application| 6306-52-1 NMR| 6306-52-1 COA| 6306-52-1 structure
[ 73913-64-1 ]
(R)-Ethyl 2-amino-3-methylbutanoate hydrochloride
Similarity: 0.95
[ 17609-47-1 ]
(S)-Ethyl 2-amino-3-methylbutanoate hydrochloride
Similarity: 0.95
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :